Covid-19 Tanısı alan hastalarda tedavi ve klinik deneyimler

Purpose : All over the world, a specific antiviral and immunomodulatory treatment method that can affect COVID-19 infection has not been found, and research is ongoing. Our goal is to share our clinical experience in patients receiving in patient treatment in our clinic. Materials and Methods: Patients whose symptoms were compatible with COVID-19 and whose microbiological findings and/ortomography findings were compatible between March 11 and May 31, 2020 were included in the study. Results: Among 180 patients included in the study; It was found that favipiravir treatment was added to 45 (25.0%) patients after HCQ treatment. A significant difference was found between treatment groups concerning; age, occupation, oxygen saturation, presence of Diabetes Mellitus, Hypertansion and lung disease, and CT findings (p